{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:49:48Z","timestamp":1792457388978,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:00:00Z","timestamp":1762646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:00:00Z","timestamp":1762646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7242036"],"award-info":[{"award-number":["7242036"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302028"],"award-info":[{"award-number":["82302028"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10067-025-07781-6","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:39:27Z","timestamp":1762652367000},"page":"343-351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical phenotypes and prognosis of IgG4-RD patients with allergy history: A retrospective cohort study"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6671-3017","authenticated-orcid":false,"given":"Chao","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6244-9917","authenticated-orcid":false,"given":"Jian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,9]]},"reference":[{"key":"7781_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1067","volume":"369","author":"M Lanzillotta","year":"2020","unstructured":"Lanzillotta M, Mancuso G, Della-Torre E (2020) Advances in the diagnosis and management of IgG4 related disease. BMJ 369:m1067. https:\/\/doi.org\/10.1136\/bmj.m1067","journal-title":"BMJ"},{"issue":"2","key":"7781_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/all.12320","volume":"69","author":"E Della Torre","year":"2014","unstructured":"Della Torre E, Mattoo H, Mahajan VS, Carruthers M, Pillai S, Stone JH (2014) Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy 69(2):269\u2013272. https:\/\/doi.org\/10.1111\/all.12320","journal-title":"Allergy"},{"issue":"5","key":"7781_CR3","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/14397595.2017.1416891","volume":"28","author":"T Saeki","year":"2018","unstructured":"Saeki T, Kobayashi D, Ito T, Tamura M, Yoshikawa S, Yamazaki H (2018) Comparison of clinical and laboratory features of patients with and without allergic conditions in IgG4-related disease: a single-center experience in Japan. Mod Rheumatol 28(5):845\u2013848. https:\/\/doi.org\/10.1080\/14397595.2017.1416891","journal-title":"Mod Rheumatol"},{"issue":"9","key":"7781_CR4","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.cgh.2017.02.007","volume":"15","author":"EL Culver","year":"2017","unstructured":"Culver EL, Sadler R, Bateman AC et al (2017) Increases in IgE, eosinophils, and mast cells can be used in diagnosis and to predict relapse of IgG4-related disease. Clin Gastroenterol Hepatol 15(9):1444-1452.e6. https:\/\/doi.org\/10.1016\/j.cgh.2017.02.007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"7781_CR5","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1002\/acr.24545","volume":"74","author":"S Sanders","year":"2022","unstructured":"Sanders S, Fu X, Zhang Y et al (2022) Lifetime allergy symptoms in IgG4-related disease: a case-control study. Arthritis Care Res 74(7):1188\u20131195. https:\/\/doi.org\/10.1002\/acr.24545","journal-title":"Arthritis Care Res"},{"issue":"9","key":"7781_CR6","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.55563\/clinexprheumatol\/3l5o9u","volume":"41","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Liu Y, Bai M et al (2023) Clinical profiles differ in IgG4-related disease with and without allergy: a large case-control study in China. Clin Exp Rheumatol 41(9):1808\u20131814. https:\/\/doi.org\/10.55563\/clinexprheumatol\/3l5o9u","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"7781_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52847-6","volume":"9","author":"X Zhang","year":"2019","unstructured":"Zhang X, Zhang P, Li J et al (2019) Different clinical patterns of IgG4-RD patients with and without eosinophilia. Sci Rep 9(1):16483. https:\/\/doi.org\/10.1038\/s41598-019-52847-6","journal-title":"Sci Rep"},{"issue":"1","key":"7781_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/art.41120","volume":"72","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Naden RP, Chari S et al (2020) The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol 72(1):7\u201319. https:\/\/doi.org\/10.1002\/art.41120","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"7781_CR9","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/S2665-9913(19)30017-7","volume":"1","author":"W Zhang","year":"2019","unstructured":"Zhang W, Stone JH (2019) Management of IgG4-related disease. Lancet Rheumatol 1(1):e55\u2013e65. https:\/\/doi.org\/10.1016\/S2665-9913(19)30017-7","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"7781_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1828-8","volume":"21","author":"M Wang","year":"2019","unstructured":"Wang M, Zhang P, Lin W et al (2019) Differences and similarities between IgG4-related disease with and without dacryoadenitis and sialoadenitis: clinical manifestations and treatment efficacy. Arthritis Res Ther 21(1):44. https:\/\/doi.org\/10.1186\/s13075-019-1828-8","journal-title":"Arthritis Res Ther"},{"issue":"13","key":"7781_CR11","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.4103\/0366-6999.184459","volume":"129","author":"Y Chen","year":"2016","unstructured":"Chen Y, Zhao JZ, Feng RE et al (2016) Types of organ involvement in patients with immunoglobulin G4-related disease. Chin Med J 129(13):1525\u20131532. https:\/\/doi.org\/10.4103\/0366-6999.184459","journal-title":"Chin Med J"},{"issue":"5","key":"7781_CR12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/joim.12942","volume":"286","author":"Y Peng","year":"2019","unstructured":"Peng Y, Li JQ, Zhang PP et al (2019) Clinical outcomes and predictive relapse factors of IgG4-related disease following treatment: a long-term cohort study. J Intern Med 286(5):542\u2013552. https:\/\/doi.org\/10.1111\/joim.12942","journal-title":"J Intern Med"},{"issue":"6","key":"7781_CR13","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1093\/rheumatology\/keaa651","volume":"60","author":"H Lu","year":"2021","unstructured":"Lu H, Teng F, Zhang P et al (2021) Differences in clinical characteristics of IgG4-related disease across age groups: a prospective study of 737 patients. Rheumatology (Oxford) 60(6):2635\u20132646. https:\/\/doi.org\/10.1093\/rheumatology\/keaa651","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"7781_CR14","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.anai.2020.03.024","volume":"124","author":"E Della-Torre","year":"2020","unstructured":"Della-Torre E, German\u00f2 T, Ramirez GA, Dagna L, Yacoub MR (2020) IgG4-related disease and allergen-specific immunotherapy. Ann Allergy Asthma Immunol 124(6):631\u2013633. https:\/\/doi.org\/10.1016\/j.anai.2020.03.024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"7781_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02489-9","volume":"23","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Mou D, Wang Z et al (2021) Clinical features and relapse risks of IgG4-related ophthalmic disease: a single-center experience in China. Arthritis Res Ther 23(1):98. https:\/\/doi.org\/10.1186\/s13075-021-02489-9","journal-title":"Arthritis Res Ther"},{"issue":"50","key":"7781_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002150","volume":"94","author":"Y Fei","year":"2015","unstructured":"Fei Y, Shi J, Lin W et al (2015) Intrathoracic involvements of immunoglobulin G4-related sclerosing disease. Medicine (Baltimore) 94(50):e2150. https:\/\/doi.org\/10.1097\/MD.0000000000002150","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"7781_CR17","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1093\/rheumatology\/kez669","volume":"59","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zeng Q, Zhu L et al (2020) Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort. Rheumatology (Oxford) 59(8):2115\u20132123. https:\/\/doi.org\/10.1093\/rheumatology\/kez669","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"7781_CR18","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.55563\/clinexprheumatol\/l7se2n","volume":"40","author":"B Ming","year":"2022","unstructured":"Ming B, Zhong J, Dong L (2022) Role of eosinophilia in IgG4-related disease. Clin Exp Rheumatol 40(5):1038\u20131044. https:\/\/doi.org\/10.55563\/clinexprheumatol\/l7se2n","journal-title":"Clin Exp Rheumatol"},{"key":"7781_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.693192","volume":"12","author":"D Michailidou","year":"2021","unstructured":"Michailidou D, Schwartz DM, Mustelin T, Hughes GC (2021) Allergic aspects of IgG4-related disease: implications for pathogenesis and therapy. Front Immunol 12:693192. https:\/\/doi.org\/10.3389\/fimmu.2021.693192","journal-title":"Front Immunol"},{"key":"7781_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.842500","volume":"13","author":"B Peng","year":"2022","unstructured":"Peng B, Sun L, Zhang M et al (2022) Role of IL-25 on eosinophils in the initiation of Th2 responses in allergic asthma. Front Immunol 13:842500. https:\/\/doi.org\/10.3389\/fimmu.2022.842500","journal-title":"Front Immunol"},{"issue":"2","key":"7781_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1165\/rcmb.2022-0236OC","volume":"68","author":"L Prince","year":"2023","unstructured":"Prince L, Mart\u00edn-Faivre L, Villeret B et al (2023) Eosinophils recruited during pulmonary vaccination regulate mucosal antibody production. Am J Respir Cell Mol Biol 68(2):186\u2013200. https:\/\/doi.org\/10.1165\/rcmb.2022-0236OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"7781_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/CM9.0000000000002755","volume":"137","author":"L Peng","year":"2024","unstructured":"Peng L, Zhang X, Zhou J et al (2024) Comparison of clinical features and outcomes of proliferative, fibrotic, and mixed subtypes of IgG4-related disease: a retrospective cohort study. Chin Med J (Engl) 137(3):303\u2013311. https:\/\/doi.org\/10.1097\/CM9.0000000000002755","journal-title":"Chin Med J (Engl)"},{"issue":"9","key":"7781_CR23","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1093\/rheumatology\/keaa221","volume":"59","author":"M Lanzillotta","year":"2020","unstructured":"Lanzillotta M, Campochiaro C, Mancuso G et al (2020) Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes. Rheumatology (Oxford) 59(9):2435\u20132442. https:\/\/doi.org\/10.1093\/rheumatology\/keaa221","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"7781_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/joim.13477","volume":"292","author":"Z Liu","year":"2022","unstructured":"Liu Z, Peng Y, Li J et al (2022) Prediction of new organ onset in recurrent immunoglobulin G4-related disease during 10 years of follow-up. J Intern Med 292(1):91\u2013102. https:\/\/doi.org\/10.1111\/joim.13477","journal-title":"J Intern Med"},{"issue":"2","key":"7781_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-216945","volume":"81","author":"E Della-Torre","year":"2022","unstructured":"Della-Torre E, Lanzillotta M, Yacoub MR (2022) Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. Ann Rheum Dis 81(2):e24. https:\/\/doi.org\/10.1136\/annrheumdis-2020-216945","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7781_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003026","volume":"9","author":"M Kanda","year":"2023","unstructured":"Kanda M, Kamekura R, Sugawara M et al (2023) IgG4-related disease administered dupilumab: case series and review of the literature. RMD Open 9(1):e003026. https:\/\/doi.org\/10.1136\/rmdopen-2023-003026","journal-title":"RMD Open"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07781-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07781-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07781-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T09:41:22Z","timestamp":1769679682000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07781-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,9]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7781"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07781-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,9]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was authorized by the Ethical Committee of the Chinese PLA General Hospital (S2016-060\u201301). Written informed consent was obtained from all patients before entry into the study and the work was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}},{"value":"No authors have any conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}